Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...

D. Boral Capital reiterated their buy rating on shares of UroGen Pharma (NASDAQ:URGN – Free Report) in a report released on Tuesday morning,Benzinga reports. D. Boral Capital currently has a $25.00 ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

The Phase II trial saw Recce 327 achieving all primary and secondary endpoints as the company looks to launch a Phase III ...

Recce Pharmaceuticals Ltd (ASX:RCE) has yielded positive data on the effectiveness of its topical gel in treating Acute ...

Available exclusively through Fox Pharma, the latest aesthetic innovation, VITARAN harnesses the power of trout DNA for a ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) will likely be posting its quarterly earnings results before the ...

Thermosensitive polymer solutions and hydrogels show great potential for thermochromic windows. However, current research often overlooks two critical factors: thermal stability under heating and ...

Within the major group of semisolid preparations, the use of hydrogel has expanded, both in cosmetics and in pharmaceutical preparations (Gowda et al., 2016). Hydrogels are appropriate for wound ...